TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07623668: Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research

Sponsor: Oculis · Phase: PHASE3 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 210 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$15,086,080

Rescue Site Savings

+$9,947,384

Unlock Full NCT07623668 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07623668 Rescue Dossier →